Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised EQT AB in connection with its inaugural 500 MEUR bond
Mandate

Vinge has advised EQT AB in connection with its inaugural 500 MEUR bond

May 17, 2021 Banking and Finance Financial Regulatory

EQT AB (publ) has completed the issuance of a EUR 500,000,000 sustainability-linked bond maturing in 2031. The bond’s coupon is subject to an increased rate upon the occurrence of triggers linked to certain sustainability performance targets.

Vinge, together with Latham & Watkins, advised EQT AB.

The Vinge team consisted primarily of Louise Brorsson Salomon, Pauline Lagerstrand, Jolinn Uhlin, Linnéa Sellström, Emma Stuart-Beck, Henrik Schön and Lave White.

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025